---
schema_version: "secwatch.filing_event.v1"
accession: "0001671284-23-000032"
form_type: "8-K"
ticker: null
cik: "0001671284"
company_name: "NeueHealth, Inc."
filed_at: "2023-08-07T23:59:59+00:00"
generated_at: "2026-06-12T04:26:34.039986+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Bright Health secures $60M NEA credit facility at 15%, permanent waiver of default, warrants up to 1.66M shares at $0.01

## Summary
- $60M delayed draw credit facility with NEA; 15% interest p.a., maturity Dec 31, 2025, commitment fee 0.50%.
- Permanent waiver of minimum liquidity covenant in existing credit facility; new minimum liquidity of $25M.
- Issuance of penny warrants to purchase up to 1,656,789 shares at $0.01/share; shareholder approval omitted due to financial viability concern; NYSE approved exception.
- Financing intended to support working capital pending close of California Medicare Advantage sale to Molina Healthcare.
- Company to report Q2 2023 earnings on Aug 9, 2023.

## SEC filing metadata
- accession: 0001671284-23-000032
- form_type: 8-K
- cik: 0001671284
- company_name: NeueHealth, Inc.
- filed_at: 2023-08-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671284/000167128423000032/0001671284-23-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671284/000167128423000032/bhg-20230804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001671284-23-000032
- JSON: https://secwatch.observer/filing/0001671284-23-000032.json
- Plain text: https://secwatch.observer/filing/0001671284-23-000032.txt

## Key facts
- Debt Financings
  NeueHealth, Inc. incurred term loan of $60.0 million with NEA 18 Venture Growth Equity, L.P. at 15.00% maturing December 31, 2025.
  - Instrument: term loan
  - Principal: $60.0 million
  - Counterparty: NEA 18 Venture Growth Equity, L.P.
  - Rate: 15.00%
  - Maturity: December 31, 2025
  - Event: incurrence
  source text: to provide for a credit facility pursuant to which, among other things, the lenders have provided $60.0 million delayed draw term loan commitments.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671284/000167128423000032/0001671284-23-000032-index.htm
- Material Agreements
  NeueHealth, Inc. entered into Credit Agreement with NEA 18 Venture Growth Equity, L.P. valued at $60.0 million (effective 2023-08-04).
  - Action: entry
  - Agreement: credit facility
  - Counterparty: NEA 18 Venture Growth Equity, L.P.
  - Value: $60.0 million
  - Effective: 2023-08-04
  source text: On August 4, 2023, Bright Health Group, Inc. (the “Company”) entered into a Credit Agreement (as amended, supplemented, restated or otherwise modified from time to time, the “New Credit Agreement”), among the Company, NEA 18 Venture Growth Equity, L.P. ("NEA") and the lenders from time to time party thereto (together with NEA and each of their respective successors and assigns, the “Lenders”), to provide for a credit facility pursuant to which, among other things, the lenders have provided $60.0 million delayed draw term loan commitments.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671284/000167128423000032/0001671284-23-000032-index.htm
- Material Agreements
  NeueHealth, Inc. amended third amended and restated limited waiver and consent with JPMorgan Chase Bank, N.A., as administrative agent (effective 2023-08-04).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: JPMorgan Chase Bank, N.A., as administrative agent
  - Effective: 2023-08-04
  source text: On August 4, 2023, the Company entered into a third amended and restated limited waiver and consent (the “New Waiver”) under the Credit Agreement, dated as of March 1, 2021 (as amended by Amendment No. 1 dated as of August 2, 2021, Amendment No. 2 dated as of November 20, 2021, Amendment No. 3 dated as of November 8, 2022, Amendment No. 4 dated as of June 23, 2023 and as further amended, supplemented or otherwise modified from time to time prior to the date hereof, the “Existing Credit Agreement”), by and among the Company, JPMorgan Chase Bank, N.A., as administrative agent (the “Administrative Agent”), and the lenders party thereto.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1671284/000167128423000032/0001671284-23-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.